Medincell receives FDA approval for WELTRUZA™ (olanzapine)
Medincell said the U.S. FDA approved its WELTRUZA™ (olanzapine). The company plans an investor webcast to discuss the approval’s implications.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.